Addex Therapeutics operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Addex Therapeutics with three other
pharmaceutical manufacturers in Europe:
sales of 2.01 million Euros [US$2.33 million]
of which 893%
(26.62 million Danish Kroner [US$4.16 million]
of which 44%
was The NGAL test), and
based in SWEDEN
(12.46 million Swedish Kronor [US$1.36 million]
Addex Therapeutics reported sales of 2.83 million Swiss Francs (US$3.06 million)
December of 2019.
decrease of 57.7%
versus 2018, when the company's sales were 6.70 million Swiss Francs.